FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
Experts were concerned about rare risk of aggressive tumors in patients using the medsContinue Reading
Experts were concerned about rare risk of aggressive tumors in patients using the medsContinue Reading
But the alternative to immediate treatment isn’t for all men, researchers sayContinue Reading
Provenge extends survival by about four months on average, costs $93,000 per individualContinue Reading
But excessive consumption is always damaging, doctors sayContinue Reading
But rates of prescription drug abuse are similar, survey findsContinue Reading
Study finds link between hormone Rx, colorectal tumors, but absolute risk is small, experts sayContinue Reading
Doctors should use androgen deprivation with caution, study saysContinue Reading
Tumors in people who never smoked had more genetic abnormalities, study saysContinue Reading
Financial incentives influence treatment rates, study findsContinue Reading
But study found women with paternal family history 5 times less likely to be referred to counselingContinue Reading
Older men were more likely to go for needed visitsContinue Reading
But industry rep counters that study of Chinese workers isn’t relevant to U.S. consumersContinue Reading
Barbers who offer BP checks help customers beat hypertension, study findsContinue Reading
Harvard researchers found downside to saturated and monounsaturated fatsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.